Market Place
Sourcing Support
Health Canada Issues Recall of Celgene Inc`s ISTODAX (romidepsin) – Restricted Access Program
20 Mar 2023 //
HEALTH CANADA
Romidepsin for Injection Available from Fresenius Kabi
12 Jul 2022 //
BUSINESSWIRE
FDA officially pulls a BMS accelerated approval, and Teva copycat falls with it
07 May 2022 //
ENDPTS
Fresenius Kabi`s Generic Romidepsin Receives Approval in the US
15 Oct 2021 //
FDA
Enforcement Report - Week of March 24, 2021
24 Mar 2021 //
FDA
ChromaDex announces an exclusive worldwide patent license & research agreement
12 Jun 2017 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.